The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe?

Cytokine and Growth Factor Reviews

Volumn 17, Issue 6, 2006, Pages 411-421

  Andersen, J B ^a,b   Hassel, B A ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b Department of Microbiology and Immunology ^*  (United States)

Author keywords

Cancer; Interferon; ISG15; Ubiquitin; Ubiquitin like protein

Indexed keywords

INTERFERON; UBIQUITIN;

ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; CELL ACTIVITY; CELL FUNCTION; CYTOKINE RELEASE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; INTERFERON STIMULATED GENE; LEUKEMIA CELL; MICROBIAL ACTIVITY; MUTATION; PRIORITY JOURNAL; PROTEIN FAMILY; RNA TRANSLATION; SHORT SURVEY; TUMOR SUPPRESSOR GENE; UPREGULATION;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTERFERONS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; UBIQUITIN; UBIQUITINS;

EID: 33751257187     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2006.10.001     Document Type: Short Survey

References (118)

1. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. Proc R Soc B 147 (1957) 258-267
2. Gresser I. Antitumor effects of interferon. Acta Oncol 28 3 (1989) 347-353
3. Borden E.C., et al. Second-generation interferons for cancer: clinical targets. Semin Cancer Biol 10 2 (2000) 125-144
4. Gibson A.D. Updated meta analysis finds that interferon-alpha improves progression-free and overall survival in low-grade non-Hodgkin's lymphoma when administered with chemotherapy that contains anthracycline or mitoxantrone. Clin Lymphoma 3 2 (2002) 82-84
5. Muller M., et al. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366 6451 (1993) 129-135
6. Velazquez L., et al. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70 2 (1992) 313-322
7. Kalvakolanu D.V. Interferons and cell growth control. Histol Histopathol 15 2 (2000) 523-537
8. Sangfelt O., Erickson S., and Grander D. Mechanisms of interferon-induced cell cycle arrest. Front Biosci 5 (2000) D479-D487
9. Ostlund L., et al. Induction of proliferation and blast transformation by interferon in human malignant and non-malignant lymph node B cells. Blood 73 8 (1989) 2171-2181
10. Xu D., et al. Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells. Blood 96 13 (2000) 4313-4318
11. Lindner D.J. Interferons as antiangiogenic agents. Curr Oncol Rep 4 6 (2002) 510-514
12. Gomez D., and Reich N.C. Stimulation of primary human endothelial cell proliferation by IFN. J Immunol 170 11 (2003) 5373-5381
13. Ruuth K., et al. Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 284 3 (2001) 583-586
14. Farrell P.J., Broeze R.J., and Lengyel P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 279 5713 (1979) 523-525
15. Reich N., et al. Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci USA 84 18 (1987) 6394-6398
16. Knight Jr. E., et al. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J Biol Chem 263 10 (1988) 4520-4522
17. Potter J.L., et al. Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein. J Biol Chem 274 35 (1999) 25061-25068
18. Boddy M.N., et al. PIC 1a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13 5 (1996) 971-982
19. Kamitani T., et al. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem 272 45 (1997) 28557-28562
20. Liu Y.C., et al. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci USA 96 8 (1999) 4313-4318
21. Haas A.L., et al. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 262 23 (1987) 11315-11323
22. Narasimhan J., et al. Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J Biol Chem 280 29 (2005) 27356-27365
23. Loeb K.R., and Haas A.L. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 267 11 (1992) 7806-7813
24. Pickart C.M. Mechanisms underlying ubiquitination. Annu Rev Biochem 70 (2001) 503-533
25. Yuan W., and Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. Embo J 20 3 (2001) 362-371
26. Kim K.I., et al. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol Cell Biol 24 21 (2004) 9592-9600
27. Zhao C., et al. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci USA 101 20 (2004) 7578-7582
28. de Veer M.J., et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69 6 (2001) 912-920
29. Nyman T.A., et al. Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes. Eur J Biochem 267 13 (2000) 4011-4019
30. Zou W., and Zhang D.E. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem 281 7 (2006) 3989-3994
31. Dastur, A., et al., Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem; 2005.
32. Li X.L., et al. RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J Biol Chem 275 12 (2000) 8880-8888
33. Liu L.Q., et al. A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation. Mol Cell Biol 19 4 (1999) 3029-3038
34. Malakhov M.P., et al. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 277 12 (2002) 9976-9981
35. Kang D., et al. Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH. Gene 267 2 (2001) 233-242
36. Hamerman J.A., et al. Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol 168 5 (2002) 2415-2423
37. Malakhov M.P., et al. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 278 19 (2003) 16608-16613
38. Zhao C., et al. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 102 29 (2005) 10200-10205
39. Giannakopoulos N.V., et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 336 2 (2005) 496-506
40. Meraro D., et al. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J Immunol 168 12 (2002) 6224-6231
41. Rosenbauer F., et al. Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages. Blood 94 12 (1999) 4274-4281
42. Liu M., Reimschuessel R., and Hassel B.A. Molecular cloning of the fish interferon stimulated gene. 15 kDa (ISG15) orthologue: a ubiquitin-like gene induced by nephrotoxic damage. Gene 298 2 (2002) 129-139
43. Bani M.R., et al. Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts. Mol Cancer Ther 3 2 (2004) 111-121
44. Matsumura Y., et al. 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal cancer cells. Anticancer Res 25 5 (2005) 3271-3278
45. Takeuchi T., and Yokosawa H. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem Biophys Res Commun 336 1 (2005) 9-13
46. Zou W., et al. ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem Biophys Res Commun 336 1 (2005) 61-68
47. Takeuchi T., et al. Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme. J Biochem (Tokyo) 138 6 (2005) 711-719
48. Takeuchi T., et al. Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation. FEBS Lett 580 18 (2006) 4521-4526
49. Ritchie K.J., et al. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev 16 17 (2002) 2207-2212
50. Kim K.I., et al. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 26 2 (2006) 472-479
51. Osiak A., et al. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25 15 (2005) 6338-6345
52. Malakhova O.A., et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. Embo J 25 11 (2006) 2358-2367
53. Knobeloch K.P., et al. Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol Cell Biol 25 24 (2005) 11030-11034
54. Lenschow D.J., et al. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79 22 (2005) 13974-13983
55. Knight Jr. E., and Cordova B. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J Immunol 146 7 (1991) 2280-2284
56. D'Cunha J., et al. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 157 9 (1996) 4100-4108
57. Recht M., Borden E.C., and Knight Jr. E. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol 147 8 (1991) 2617-2623
58. Austin K.J., et al. Interferon-stimulated gene-15 (Isg15) expression is up-regulated in the mouse uterus in response to the implanting conceptus. Endocrinology 144 7 (2003) 3107-3113
59. Pru J.K., et al. Production, purification, and carboxy-terminal sequencing of bioactive recombinant bovine interferon-stimulated gene product 17. Biol Reprod 63 2 (2000) 619-628
60. Owhashi M., et al. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem Biophys Res Commun 309 3 (2003) 533-539
61. Kok K., et al. A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin-activating enzyme. Proc Natl Acad Sci USA 90 13 (1993) 6071-6075
62. McLaughlin P.M., et al. The ubiquitin-activating enzyme E1-like protein in lung cancer cell lines. Int J Cancer 85 6 (2000) 871-876
63. Kok K., et al. The genomic structure of the human UBE1L gene. Gene Exp. 4 3 (1995) 163-175
64. Malakhova O.A., et al. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev 17 4 (2003) 455-460
65. Pitha-Rowe I., Hassel B.A., and Dmitrovsky E. Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J Biol Chem 279 18 (2004) 18178-18187
66. Kitareewan S., et al. UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukaemia. Proc Natl Acad Sci USA 99 6 (2002) 3806-3811
67. Pitha-Rowe I., et al. Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemoprevention. Cancer Res 64 21 (2004) 8109-8115
68. Pelicano L., et al. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction. Oncogene 18 27 (1999) 3944-3953
69. Dao C.T., Luo J.K., and Zhang D.E. Retinoic acid-induced protein ISGylation is dependent on interferon signal transduction. Blood Cells Mol Dis 36 3 (2006) 406-413
70. Liu M., Hummer B.T., Li X.L., and Hassel B.A. Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon. Interferon Cytokine Res 24 (2004) 647-654
71. Desai S.D., et al. Ubiquitin, SUMO-1, and UCRP in camptothecin sensitivity and resistance. Ann N Y Acad Sci 922 (2000) 306-308
72. Hermeking H., et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1 1 (1997) 3-11
73. Kim T., et al. Activation of interferon regulatory factor 3 in response to DNA-damaging agents. J Biol Chem 274 43 (1999) 30686-30689
74. Polyak K., et al. A model for p53-induced apoptosis. Nature 389 6648 (1997) 300-305
75. Ragnarsson G., et al. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 79 9-10 (1999) 1468-1474
76. Rajgopal A., et al. Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis. Cancer Genet Cytogenet 142 1 (2003) 46-50
77. Tripathi M.K., and Chaudhuri G. Down-regulation of UCRP and UBE2L6 in BRCA2 knocked-down human breast cells. Biochem Biophys Res Commun 328 1 (2005) 43-48
78. D'Cunha J., et al. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci USA 93 1 (1996) 211-215
79. Dunn G.P., Old L.J., and Schreiber R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21 2 (2004) 137-148
80. Padovan E., et al. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res 62 12 (2002) 3453-3458
81. Remmel E., et al. Modulation of dendritic cell phenotype and mobility by tumor cells in vitro. Hum Immunol 62 1 (2001) 39-49
82. Reichert T.E., et al. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 91 11 (2001) 2136-2147
83. Schwaab T., et al. Dendritic cell infiltration in colon cancer. J Immunother 24 2 (2001) 130-137
84. Campisi J. Suppressing cancer: the importance of being senescent. Science 309 5736 (2005) 886-887
85. Braig M., et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 7051 (2005) 660-665
86. Chen Z., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 7051 (2005) 725-730
87. Collado M., et al. Tumour biology: senescence in premalignant tumours. Nature 436 7051 (2005) p642
88. Michaloglou C., et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 7051 (2005) 720-724
89. Xin H., Pereira-Smith O.M., and Choubey D. Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene 23 37 (2004) 6209-6217
90. Leszczyniecka M., et al. Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPase(old-35), a Type I interferon inducible early response gene. Gene 316 (2003) 143-156
91. Shou J., et al. Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci USA 99 5 (2002) 2830-2835
92. Untergasser G., et al. Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Res 62 21 (2002) 6255-6262
93. Yoon I.K., et al. Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Exp Gerontol 39 9 (2004) 1369-1378
94. Parrinello S., et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118 Pt 3 (2005) 485-496
95. Nalepa G., Rolfe M., and Harper J.W. Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov 5 7 (2006) 596-613
96. Liu M., Li X.L., and Hassel B.A. Proteasomes modulate conjugation to the ubiquitin-like protein ISG15. J Biol Chem 278 3 (2003) 1594-1602
97. Desterro J.M., Rodriguez M.S., and Hay R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2 2 (1998) 233-239
98. Desai S.D., et al. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 66 2 (2006) 921-928
99. Ruckes T., et al. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood 98 4 (2001) 1150-1159
100. Siddoo-Atwal C., Haas A.L., and Rosin M.P. Elevation of interferon beta-inducible proteins in ataxia telangiectasia cells. Cancer Res 56 3 (1996) 443-447
101. Iacobuzio-Donahue C.A., et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 162 4 (2003) 1151-1162
102. Andersen J.B., et al. Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br J Cancer 94 10 (2006) 1465-1471
103. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4 1 (2004) 71-78
104. Blattman J.N., and Greenberg P.D. Cancer immunotherapy: a treatment for the masses. Science 305 5681 (2004) 200-205
105. Paterson H.M., et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 171 3 (2003) 1473-1483
106. Beg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 23 11 (2002) 509-512
107. Lin E.Y., et al. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193 6 (2001) 727-740
108. Lin E.Y., et al. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7 2 (2002) 147-162
109. Lin E.Y., and Pollard J.W. Macrophages: modulators of breast cancer progression. Novartis Found Symp 256 (2004) 158-168 [Discussion 168-172, 259-269]
110. Sun Y. E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8 8 (2006) 645-654
111. Horie-Inoue K., and Inoue S. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers. Semin Cancer Biol 16 3 (2006) 235-239
112. Li M., et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416 6881 (2002) 648-653
113. Cummins J.M., et al. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428 6982 (2004) 1 [Following 486]
114. Spano J.P., et al. Proteasome inhibition: a new approach for the treatment of malignancies. Bull Cancer 92 11 (2005) E61-E66 [945-952]
115. Kok K., Osinga J., Carritt B., Davis M.B., van der Hout A.H., van der Veen A.Y., et al. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 330 6148 (1987) 578-581
116. Nakayama H., Sano T., Motegi A., Oyama T., Nakajima T., et al. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma. Pathol Int. 55 11 (2005) 707-715
117. Suzuki T., Urano T., Tsukui T., Horie-Inoue K., Moriya T., Ishida T., et al. Estrogen-responsive finger protein as a new potential biomarker for breast cancer. Clin Cancer Res 11 17 (2005) 6148-6154
118. Mitsui K., Nakanishi M., Ohtsuka S., Norwood T.H., Okabayashi K., Miyamoto C., et al. A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins. Biochem Biophys Res Commun 266 1 (1999) 115-122